CTI BIOPHARMA CORP·4

Mar 11, 7:45 PM ET

Parkinson David Ross 4

4 · CTI BIOPHARMA CORP · Filed Mar 11, 2022

Insider Transaction Report

Form 4
Period: 2022-03-09
Transactions
  • Award

    Stock Option (right to buy)

    2022-03-09+80,00080,000 total
    Exercise: $4.49Exp: 2032-03-09Common Stock (80,000 underlying)
Footnotes (1)
  • [F1]This stock option vests on the first to occur of (i) the date that is twelve months after the date of grant, and (ii) immediately prior to the first annual meeting of the Company's stockholders in 2023 at which one or more members of the Company's Board of Directors are to be elected, subject to the Reporting Person's continued service through such date or event.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION